KEW, Inc.

KEW, Inc. is a comprehensive genomic profiling company, dedicated to revolutionizing cancer care by providing therapeutic options based on an individual patient’s tumor genetic profile with CANCERPLEX®, our flagship clinical product for identifying genetic variants and matching them with targeted therapies in solid tumors. Based in Cambridge, MA, KEW was founded by pioneers of the precision medicine industry, including key contributors to the Human Genome and The Cancer Genome Atlas projects. As increasing evidence puts precision medicine at the forefront in the fight against cancer, we have recognized the growing need for expanded patient access to comprehensive genomic profiling to guide better treatment decisions and quality patient care in local community practice. To address this critical, unmet need, we are now partnering with and enabling molecular labs to expand their precision medicine programs to adopt CANCERPLEX® for optimal cancer care in their local laboratories. We couldn't have done it without our top-notch staff. You can view all of our career opportunities at www.kewinc.com/careers